Melanoma Canada is deeply concerned by the Government of Canada’s decision to impose a 50% retaliatory tariff on certain U.S.-imported sunscreen products. While we recognize the need for Canada to respond to international trade measures and protect Canadian industries, sunscreen should not be caught in the crossfire of a trade dispute.
Sunscreen is not a luxury or simply a cosmetic product. It is an important skin cancer prevention tool. Increasing its cost creates another barrier for Canadians at a time when affordability is already a significant concern for families.
Skin cancer is the most common cancer in Canada, and the vast majority of cases are associated with exposure to ultraviolet radiation. Regular use of broad-spectrum sunscreen, alongside shade, protective clothing and other sun-safe behaviours, is an important part of reducing that risk.
A 50% tariff on imported sunscreen has the potential to increase retail prices and reduce consumer choice, disproportionately affecting families, outdoor workers and others who require frequent sun protection. Public policy should be making proven cancer-prevention measures more accessible, not more expensive!
Melanoma Canada is calling on the federal government to immediately exempt sunscreen from these retaliatory tariffs or provide tariff remission for sunscreen products, and to work toward broader measures that make sun protection more affordable for Canadians.
We would also encourage governments to go further by examining the removal of GST/HST and applicable provincial sales taxes on sunscreen and exploring coverage of sunscreen for people at particularly high risk of skin cancer, including those with a previous skin cancer diagnosis.
Trade policy should not inadvertently undermine public health policy. Canadians should never have to choose between protecting their skin and protecting their household budget.
Falyn Katz.
CEO
Melanoma Canada
